Prelude Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38,500	Closed	-$508K	–	1302
2025 Q1	$508K	Sell	38,500 -1,336	-3%	-$18.4K	0.05%	513
2024 Q4	$629K	Sell	39,836 -16,979	-30%	-$255K	0.05%	505
2024 Q3	$903K	Buy	56,815 +315	+0.6%	+$5.07K	0.07%	415
2024 Q2	$861K	Sell	56,500 -18,500	-25%	-$265K	0.07%	353
2024 Q1	$1.1M	Hold	75,000	–	–	0.08%	373
2023 Q4	$1.04M	Hold	75,000	–	–	0.09%	294
2023 Q3	$1M	Hold	75,000	–	–	0.09%	302
2023 Q2	$947K	Hold	75,000	–	–	0.08%	315
2023 Q1	$854K	Sell	75,000 -380	-0.5%	-$4.1K	0.06%	337
2022 Q4	$780K	Buy	75,380 +380	+0.5%	+$4.1K	0.05%	432
2022 Q3	$785K	Buy	75,000 +18,320	+32%	+$195K	0.04%	493
2022 Q2	$628K	Sell	56,680 -18,320	-24%	-$199K	0.03%	694
2022 Q1	$836K	Buy	75,000 +24,500	+49%	+$278K	0.04%	657
2021 Q4	$661K	Sell	50,500 -15,500	-23%	-$195K	0.03%	852
2021 Q3	$860K	Hold	66,000	–	–	0.05%	629
2021 Q2	$970K	Hold	66,000	–	–	0.05%	629
2021 Q1	$810K	Hold	66,000	–	–	0.06%	686
2020 Q4	$941K	Hold	66,000	–	–	0.08%	492
2020 Q3	$918K	Hold	66,000	–	–	0.13%	289
2020 Q2	$700K	Buy	+66,000	New	+$671K	0.11%	397